EMAIL DETAILS
SUBJECT:
Pembrolizumab
PRI: HIGH
FROM:
W
wyung@mdanderson.org
DATE:
2015-01-09 20:44:09
MSG_ID:
<E92355D42D753546BBE0D1DA4FEF8F0315E93042@DCPWPEXMBX02.mdanderson.edu>
RECIPIENTS:
TO:
2
Beau Biden
<261penn@gmail.com>
H
halliebiden@gmail.com
H
hbiden@rosemontseneca.com
H
Howard Krein
<howard.krein@jefferson.edu>
CC:
E
Lee,Evalu T
<etlee@mdanderson.org>
CONTENT:
TEXT: YES |
HTML: YES
PROCESSED
Good news, the insurance thru Express Script said Pembrolizumab is covered. So it will be there when we want to activate it. This is wonderful. Al W.K. Alfred Yung, M.D. Chairman, Department of Neuro-Oncology Margaret and Ben Love Chair in Clinical Cancer Care UT M. D. Anderson Cancer Center, Unit 431 1515 Holcombe Blvd Houston, TX 77030 Tele: 713-794-1285 Fax: 713-563-0151 wyung@mdanderson.org From: Hawkins,Sharon Sent: Friday, January 09, 2015 1:33 PM To: Yung,W K Alfred; Lee,Evalu T; Abreu,Tamu M Cc: Brain Spine BCRN; Hagerman,Chris Subject: RE: update/Lincoln Importance: High I just received a call from Express Scripts. The representative was calling on behalf of Mr. Nadur. Pembrolizumab is a covered benefit. He ran a test claim and it passed. He is notating in pharm system to approve the drug. So, you can contact family, obtain local pharmacy info and e-RX. I am sure it will take them a few days to obtain the meds. Sharon Hawkins, RN, BSN, OCN Brain & Spine Patient Access Center 7am-3:30pm CST 713.792.5409 telephone 713.792.5395 fax
METADATA:
THREAD:
TOPIC:
Pembrolizumab
INDEX:
AdAsTP2vn+Ata7OSQLm+loGBIDv78w==